-
-
Login
Dexcom has agreed to acquire Nutrisense, bringing nutrition coaching and metabolic health services into its growing ecosystem. The deal offers the clearest sign yet that the future of CGM could extend far beyond traditional diabetes management.
EOFlow has secured a significant legal victory after a US appeals court overturned a $59.4 million judgment awarded to Insulet in the long-running dispute between the two patch pump manufacturers.
Insulet has recalled specific Omnipod pods after a fault linked to insulin under-delivery, high glucose and DKA.
Dexcom has warned that some G7 sensors intended for destruction after failing company quality standards were allegedly stolen and resold through unofficial supply channels, triggering concern across diabetes forums about counterfeit and diverted CGM devices entering circulation.
Beta Bionics says its Mint patch pump will launch in 2027, taking aim at market leader Omnipod with a tubeless insulin pump that promises FreeStyle Libre compatibility, smartphone control and a fully adaptive insulin algorithm. But the bigger opportunity may not be winning over existing Omnipod users at all.
Abbott has secured CE mark approval for Libre Duo, its new dual glucose-ketone sensor designed for people with diabetes. The launch could mark one of the biggest diabetes safety developments since hybrid-closed loop systems became mainstream.
Dexcom’s Investor Day gave the clearest public preview yet of G8 CGM. From launch timing and 15-day wear to a smaller sensor and future ketone sensing, here’s what users need to know.
Insulet has upgraded its 2026 revenue forecast after a strong start to the year, driven by global demand for Omnipod systems. Alongside growth, new details from regulators, analysts and safety updates provide a fuller picture of where the company — and the wider hybrid-closed loop market — is heading.
An in-depth report on the effects of conflict in the region and what this could mean for diabetes technology and insulin supply across the Middle East and Europe.
Insulet recalls small proportion of its Omnipod 5 insulin patch pump pods after identifying a manufacturing issue that could lead to under-delivery of insulin.
FreeStyle Libre news in March 2026 centres on a key change for UK prescriptions and several international developments.
Tandem Mobi insulin pump launches on Android in the US but despite CE mark has yet to be available in Europe.
